Trial shows improvements in several clinical outcomes for men with intermediate-risk prostate cancer
by NRG OncologyCredit: Unsplash/CC0 Public DomainResults from the phase 3 NRG Oncology RTOG 0815 clinical study comparing dose-escalated radiotherapy (RT) alone to dose-escalated RT with short-term an
Updated on: January 04,2024
Trial shows improvements in several clinical outcomes for men with intermediate-risk prostate cancer
by NRG OncologyCredit: Unsplash/CC0 Public DomainResults from the phase 3 NRG Oncology RTOG 0815 clinical study comparing dose-escalated radiotherapy (RT) alone to dose-escalated RT with short-term an
Updated on:January 04,2024
